CD274 and neoplasm: In this respect, the study by Herbst et al. is noteworthy, which showed that PD-L1 scoring on both tumor and immune cells in the tumor microenvironment may be more accurate in predicting response compared to the sole PD-L1 assessment on tumor cells [45].